A/s Novo is 10% at BIOMIMETIC THERAPEUTICS, INC. (BMTI). They have made 69 open-market trades across 18 companies since 2007, most recently 2026-10-01.
CIK 0001370053
52 open-market purchases totalling $127.5M since 2007, against 17 sales. Across 18 scored buys the stock is up 9.6% at ninety days, and 7.6 points ahead of the S&P over the same stretch.
18 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 33% | 50% | 50% |
| Avg Move | -5.4% | +4.6% | +9.6% |
| Alpha | -2.2% | +3.8% | +7.6% |
| Scored | 18 | 18 | 18 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 65% | 47% | 41% |
| Avg Move | -5.9% | -5.8% | +37.6% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANAB | SELL · 10b5-1 | 2026-10-01 | 2026-10-02 | $49.87 | $249K | -5.0% | -4.1% | — |
| RETA | SELL | 2017-06-13 | 2017-06-14 | $25.11 | $1.5M | +21.5% | +31.3% | +17.2% |
| RETA | SELL | 2017-06-08 | 2017-06-12 | $25.71 | $5.7M | +14.7% | +33.6% | +15.2% |
| RETA | SELL | 2017-06-05 | 2017-06-07 | $28.24 | $2.5M | +2.7% | +16.7% | +3.7% |
| APEN | SELL | 2017-05-10 | 2017-05-11 | $5.62 | $590K | -7.1% | -2.1% | -19.1% |
| ANAB | BUY | 2017-01-31 | 2017-02-01 | $15.00 | $750K | +37.8% | +34.7% | +56.0% |
| OPHT | SELL | 2016-12-14 | 2016-12-16 | $4.87 | $17.6M | -4.6% | -8.7% | -29.2% |
| RARX | BUY | 2016-10-31 | 2016-11-02 | $13.00 | $3.2M | +8.4% | +0.4% | +23.5% |
| IRTC | BUY | 2016-10-25 | 2016-10-26 | $17.00 | $1.7M | -9.8% | +12.5% | +16.9% |
| CLCD | BUY | 2016-09-09 | 2016-09-13 | $20.00 | $2.0M | +39.8% | +63.3% | +66.2% |
| TBRA | SELL | 2016-07-11 | 2016-07-13 | $12.02 | $710K | -62.3% | -61.4% | +240.7% |
| TBRA | SELL | 2016-07-05 | 2016-07-07 | $12.20 | $1.1M | -8.1% | -67.5% | +235.6% |
| TBRA | SELL | 2016-06-28 | 2016-06-30 | $13.03 | $871K | -6.3% | -67.8% | +211.6% |
| TBRA | SELL | 2016-06-06 | 2016-06-07 | $10.37 | $1.9M | +15.0% | +14.4% | -53.0% |
| RETA | BUY | 2016-06-01 | 2016-06-02 | $11.00 | $8.3M | +37.2% | +12.0% | +20.0% |
| OPHT | SELL | 2016-05-24 | 2016-05-25 | $49.00 | $63.7M | +12.2% | +2.1% | +7.9% |
| CRVS | BUY | 2016-05-12 | 2016-05-16 | $10.00 | $700K | +21.3% | +0.4% | +19.5% |
| CRVS | BUY | 2016-03-29 | 2016-03-30 | $15.00 | $10.0M | -3.0% | -18.2% | -6.7% |
| TBRA | SELL | 2016-03-02 | 2016-03-04 | $6.80 | $1.3M | +18.3% | +17.7% | +41.3% |
| TBRA | SELL | 2015-11-17 | 2015-11-19 | $9.79 | $2.2M | -27.9% | +4.0% | -23.1% |
| FLXN | SELL | 2015-06-18 | 2015-06-22 | $20.62 | $3.1M | -19.2% | -4.0% | -4.0% |
| CLCD | BUY | 2015-05-11 | 2015-05-12 | $10.00 | $13.0M | -18.6% | +1.2% | +1.2% |
| HTGM | BUY | 2015-05-11 | 2015-05-12 | $14.00 | $5.1M | -0.7% | -3.8% | -3.8% |
| TBRA | BUY | 2015-05-04 | 2015-05-06 | $10.62 | $8.9M | -27.9% | +4.0% | +4.0% |
| OPHT | SELL | 2015-03-05 | 2015-03-09 | $51.75 | $52.0M | -14.7% | -4.1% | -4.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| CRVS | 3,224,046 | $34.1M |
| INGN | 3,549,320 | $25.6M |
| APEN | 1,351,972 | $13.5M |
| NVRO | 2,194,841 | $12.8M |
| OPHT | 1,405,487 | $2.0M |
| AKBA | 1,333,797 | $921K |
| HTGM | 1,280,185 | $614K |
| ANAB | 10,995 | $523K |
| OTIC | 2,175,025 | $167K |
| BMTI | 4,720,065 | — |
| ZSPH | 506,730 | — |
| Total | $899.6M |
Shares reported on the most recent Form 4, priced at the 2026-10-02 close. 2 holdings could not be priced and are excluded from the total.
| Scored | 17 | 17 | 17 |